BMC Infectious Diseases

official impact factor 2.83
Search for
Advanced search
BMC Infectious Diseases
Tools
Share this article
Open Access Pre-publication history

Incidence and risk factors for liver enzyme elevation during highly active antiretroviral therapy in HIV-HCV co-infected patients: results from the Italian EPOKA-MASTER Cohort

Carlo Torti*, Giuseppe Lapadula, Salvatore Casari, Massimo Puoti, Mark Nelson, Eugenia Quiros-Roldan, Daniele Bella, Giuseppe Pastore, Nicoletta Ladisa, Lorenzo Minoli, Giovanni Sotgiu, Francesco Mazzotta, Sergio Lo Caputo, Giovanni Di Perri, Gaetano Filice, Carmine Tinelli, Giampiero Carosi and the EPOKA-MASTER Study Group

BMC Infectious Diseases 2005, 5:58 doi:10.1186/1471-2334-5-58

Pre-publication versions of this article and reviewers' reports

Original Submission - Version 1 Manuscript 01 Feb 2005
Reviewer's Report Juan Macías 21 Feb 2005
Reviewer's Report Uberti-Foppa Caterina 25 Feb 2005
Reviewer's Report Ulrich Spengler 02 Mar 2005
Reviewer's Report Bendix Carstensen 08 Mar 2005
Resubmission - Version 2 Manuscript 11 Apr 2005
Resubmission - Version 3 Manuscript Author's comment 11 Apr 2005
Reviewer's Report Ulrich Spengler 20 Apr 2005
Reviewer's Report Juan Macías 25 Apr 2005
Reviewer's Report Uberti-Foppa Caterina 26 Apr 2005
Reviewer's Report Bendix Carstensen 04 May 2005
Resubmission - Version 4 Manuscript 03 Jun 2005
Resubmission - Version 5 Manuscript 20 Jun 2005
Reviewer's Report Bendix Carstensen 06 Jul 2005
Resubmission - Version 6 14 Jul 2005
Resubmission - Version 7 Manuscript Author's comment 14 Jul 2005
Published 14 Jul 2005